Show results for
Refine by
Biomark Software In Usa Massachusetts
17 software items found
Manufactured by:BioSensics LLC based inNewton, MASSACHUSETTS (USA)
A unified solution for collection of digital biomarkers from wearable sensors, mobile applications and digital technologies at patients’ ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Maximize your biologically actionable insights from small tumor samples with the SOPHiA DDM™ RNAtarget Technology end-to-end solutions. Gene fusions have been associated with various tumors and are recognized as valuable cancer biomarkers in cancer research1. Targeted RNA sequencing is recommended to maximize novel fusion detection by identifying transcribed and potentially ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
From targeted to comprehensive solutions, Next-Generation-Sequencing (NGS) offers the capacity to simultaneously analyze a select set of genes, regions, and biomarkers based on known involvement across solid tumor such as lung, colon, breast, melanoma, gastric, and ovarian cancers. However, as tests either expand or become more specialized, molecular pathologists now rely on ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Deeper genomic insights, fewer missed opportunities. CGP enables clinical researchers to identify actionable variants and biomarkers across hundreds of genes using a single solution. The SOPHiA DDMTM Platform offers decentralized, in-house next generation sequencing (NGS) applications that help maximize insights from CGP data by leveraging advanced analytical capabilities, ...
by:Empatica Inc. based inBoston, MASSACHUSETTS (USA)
The wearable AI system for the early detection of respiratory infections, tailored to help fight COVID-19. Reduce spread within communities and give peace of mind to your workers, students, and their ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Clinical interpretation has been one of the most complex and time-consuming aspects of transforming genomic data into meaningful results, until ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into meaningful insights can be outdated, inaccurate, costly, and time-consuming. This ultimately risks limiting researchers’ productivity, thus ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
PathExploreTM offers unprecedented spatial and cellular resolution of the tumor microenvironment (TME) from H&E images. PathExplore is an AI-powered panel of histopathology features that spatially characterize the tumor microenvironment (TME) with single-cell ...
by:Verisense Health based inCambridge, MASSACHUSETTS (USA)
The IRB-approved Verisense Digital Health Panel (DHP) bridges the gap in data between the thousands of highly targeted, but small and siloed, scientific studies and the vast, but proprietary, consumer wearables datasets which lack good outcome measures. The DHP enables the integration of many independent studies by collecting device independent raw sensor data and patient reported outcomes at ...
by:nference, Inc. based inCambridge, MASSACHUSETTS (USA)
We offer a vertically integrated, end-to-end solutions and software to make the most of your data. Maximizing your data to improve patient outcomes. We partner with you to securely process and transform your raw unstructured and semi-structured EMR data into structured data that can be used to develop solutions to healthcare’s biggest ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Pioneering Innovation, Streamlining Adoption: We are pushing the boundaries of today’s liquid biopsy capabilities. Bring liquid biopsy to your lab with our streamlined DNA-only NGS workflow, taking you from cell-free DNA sample to comprehensive report in record time. Powered by state-of-the-art proprietary algorithms, the SOPHiA DDMTM Platform reveals deep genomic insights from cell-free ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Identifying patterns of genomic scarring in ovarian cancer samples. Accurate identification and reporting of Homologous Recombination Deficiency (HRD) status are critical for better patient management. SOPHiA DDM Dx HRD Solution is a CE-marked in vitro diagnostic (IVD) application leveraging low-pass Whole Genome Sequencing (WGS) and a proprietary deep-learning algorithm. Powered by the advanced ...
Manufactured by:BioT Medical based inPetach Tikva, ISRAEL
Transform your medical devices into connected care solutions in a single day with our regulated cloud ...
by:Beacon Biosignals, Inc. based inBoston, MASSACHUSETTS (USA)
Beacon provides a scalable EEG analytics platform aimed at accelerating and de-risking therapeutics in neurology, psychiatry, and sleep medicine. Powered by a combination of unique data assets and machine learning algorithms, our platform identifies and standardizes neurobiomarkers to increase the probability of success at each stage of drug ...
by:Empatica Inc. based inBoston, MASSACHUSETTS (USA)
Empatica Care enables the continuous, remote monitoring of patients with acute and chronic conditions, or of healthy individuals who may be at risk of infection, by easing the burden on healthcare workers and facilities, and simultaneously increasing the quality of care that can be provided to ...
Manufactured by:BioSensics LLC based inNewton, MASSACHUSETTS (USA)
A transformative mobile health application for monitoring motor, speech and cognitive function, and mental ...
by:nference, Inc. based inCambridge, MASSACHUSETTS (USA)
Our scientists use the nference platform and data in collaboration with your teams to tackle your most important questions and challenges. nference is creating the largest labeled EMR dataset in healthcare. EMR data contains longitudinal real-world, “deep data” rich in clinical phenotypes and outcomes spanning across therapeutic areas, but exists in in largely semi-structured and ...